9(top 5%)
papers
2.8K(top 1%)
citations
7(top 5%)
h-index
8(top 5%)
g-index
10
all documents
3.0K
doc citations
682
citing journals

Top Articles

#TitleJournalYearCitations
1Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet, The20172,771
2Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyHepatology201779
3Hand-foot skin reaction (HFSR) and overall survival (OS) in the phase 3 RESORCE trial of regorafenib for treatment of hepatocellular carcinoma (HCC) progressing on sorafenib.Journal of Clinical Oncology201840
4LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trialAnnals of Oncology201629
5Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH TrialClinical Cancer Research201626
6Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosisHistopathology201711
7Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trialAnnals of Oncology20167
8Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatmentAnnals of Oncology20175
94:12 PM Abstract No. 379 Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatmentJournal of Vascular and Interventional Radiology20180
10Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general populationActa Radiologica00